Humphry 400 mg (Calcium Orotate) Tablets

Introduction:

Humphry 400 mg, manufactured by Beacon Pharmaceuticals Ltd and supplied by Orio Pharma, is a premium calcium supplement designed to support optimal bone health. Containing Calcium Orotate, Humphry 400 mg provides superior absorption and bioavailability, making it an effective option for maintaining strong bones and preventing osteoporosis. This formulation is particularly beneficial for individuals who require enhanced calcium intake, such as postmenopausal women, older adults, and those at risk of calcium deficiency.

Manufacturing Excellence of Beacon Pharmaceuticals Ltd.:

Beacon Pharmaceuticals Ltd. is committed to producing high-quality pharmaceutical products that meet stringent international standards. The development of Humphry 400 mg reflects Beacon’s dedication to advancing nutritional supplements through innovative research, rigorous quality control, and adherence to best manufacturing practices. Their focus on safety and efficacy ensures that Humphry 400 mg is a reliable and effective choice for supporting bone health.

Mechanism of Action:

Humphry 400 mg contains Calcium Orotate, a highly bioavailable form of calcium that is easily absorbed by the body. Calcium Orotate works by delivering calcium directly to the cells, where it is needed to support bone formation and maintenance. This form of calcium is particularly effective because it is bound to orotic acid, which facilitates its transport across cell membranes and enhances its incorporation into bone tissue. Regular supplementation with Humphry 400 mg helps to maintain adequate calcium levels, supporting bone density, and reducing the risk of osteoporosis and fractures.

Clinical Applications:

Humphry 400 mg is indicated for:

• Bone Health Maintenance: Humphry is used to support and maintain healthy bones, particularly in individuals at risk of calcium deficiency, such as postmenopausal women and older adults.
• Osteoporosis Prevention: Humphry 400 mg helps to prevent osteoporosis by ensuring adequate calcium intake, which is essential for maintaining bone density and reducing the risk of fractures.
• Calcium Deficiency: Humphry 400 mg is also effective in treating calcium deficiency, providing a highly absorbable source of calcium for individuals with increased calcium needs.

Clinical studies have demonstrated that Calcium Orotate is more effective in promoting bone health compared to other forms of calcium, due to its superior absorption and bioavailability.

Dosage and Administration:

The recommended dosage of Humphry 400 mg is one to two tablets daily, depending on individual calcium needs, as directed by a healthcare provider. The tablets should be swallowed whole with water, preferably with a meal to enhance absorption. It is important for patients to follow their healthcare provider’s instructions closely to achieve optimal calcium levels and support bone health effectively. Regular monitoring of calcium levels may be necessary to ensure that the supplementation is providing the desired benefits.

Benefits of Humphry 400 mg:

• Superior Absorption: Humphry 400 mg provides highly bioavailable calcium, ensuring better absorption and utilization by the body compared to other calcium supplements.
• Enhanced Bone Health: Regular supplementation with Humphry 400 mg supports strong bones, helps maintain bone density, and reduces the risk of osteoporosis and fractures.
• Suitable for High-Risk Groups: Humphry 400 mg is particularly beneficial for individuals at higher risk of calcium deficiency, including postmenopausal women, older adults, and those with dietary restrictions.
• Convenient Dosing: The easy-to-swallow tablets of Humphry 400 mg make it simple for patients to incorporate into their daily routine, ensuring consistent calcium intake.

Supplier: Orio Pharma

Orio Pharma ensures that Humphry 400 mg is readily available to healthcare providers and patients, offering reliable access to this essential calcium supplement. Their commitment to efficient supply and distribution supports effective management of bone health, helping to improve patient outcomes.

Conclusion:

Humphry 400 mg (Calcium Orotate) by Beacon Pharmaceuticals Ltd, supplied by Orio Pharma, represents an advanced solution for supporting bone health and preventing osteoporosis. This superior calcium supplement provides highly bioavailable calcium, ensuring optimal absorption and utilization by the body. By incorporating Humphry 400 mg into their daily regimen, individuals can maintain strong bones, reduce the risk of fractures, and improve overall bone health. Healthcare providers can confidently recommend Humphry 400 mg as a reliable and effective strategy for managing calcium levels and supporting long-term skeletal health.